http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1115692-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
filingDate 2014-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713b12276be4f7c0d3bdbc49df960d5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_752a6d757f3300a412b10465adcec1c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be17cb3b03c3c7090d4241a66fcbe12d
publicationDate 2017-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1115692-T1
titleOfInvention SELECTED ANTIBODIES BINDING TO AMINOSPHOLIPIDES AND USE THEM IN EDUCATION, AS CANCER
abstract Amazing discoveries are revealed regarding the role of anionic phospholipids and aminophospholipids in vascular tumor structure and viral entry and dissemination and compositions and methods for utilizing these findings in the treatment of cancer and viral infections. Advantageous compositions based on antibodies, immunoconjugates and duramycin are also disclosed and combinations that bind and inhibit anionic phospholipids and aminophospholipids for use in the safe and effective treatment of cancer, viral infections and infections.
priorityDate 2002-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86289378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426285082

Total number of triples: 17.